Barclays Lowers Molina Healthcare (NYSE:MOH) Price Target to $185.00

Molina Healthcare (NYSE:MOH) had its price target cut by stock analysts at Barclays from $186.00 to $185.00 in a note issued to investors on Thursday,Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Barclays‘s price objective would indicate a potential upside of 6.01% from the company’s current price.

Several other equities analysts have also issued reports on the stock. Wells Fargo & Company decreased their price target on shares of Molina Healthcare from $216.00 to $198.00 and set an “overweight” rating for the company in a report on Friday, August 15th. Morgan Stanley lowered shares of Molina Healthcare from an “overweight” rating to an “equal weight” rating and decreased their price target for the company from $364.00 to $266.00 in a report on Thursday, July 10th. Cantor Fitzgerald reissued a “neutral” rating and issued a $210.00 price target on shares of Molina Healthcare in a report on Tuesday, August 26th. Truist Financial reissued a “hold” rating and issued a $180.00 price target (down previously from $335.00) on shares of Molina Healthcare in a report on Friday, July 25th. Finally, JPMorgan Chase & Co. decreased their price target on shares of Molina Healthcare from $272.00 to $184.00 and set a “neutral” rating for the company in a report on Tuesday, July 29th. Three equities research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $225.18.

Molina Healthcare Price Performance

MOH opened at $174.51 on Thursday. The company has a fifty day moving average price of $187.75 and a two-hundred day moving average price of $269.99. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.66 and a current ratio of 1.66. Molina Healthcare has a 52 week low of $151.95 and a 52 week high of $365.23. The firm has a market capitalization of $9.46 billion, a PE ratio of 8.60 and a beta of 0.54.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings results on Wednesday, July 23rd. The company reported $5.48 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.50 by ($0.02). Molina Healthcare had a net margin of 2.60% and a return on equity of 27.72%. The firm had revenue of $11.43 billion during the quarter, compared to analyst estimates of $10.94 billion. During the same period last year, the firm earned $5.86 EPS. Molina Healthcare’s quarterly revenue was up 15.7% on a year-over-year basis. As a group, analysts anticipate that Molina Healthcare will post 24.4 earnings per share for the current year.

Insider Activity

In other Molina Healthcare news, Director Ronna Romney sold 700 shares of the business’s stock in a transaction dated Wednesday, August 6th. The shares were sold at an average price of $153.74, for a total transaction of $107,618.00. Following the sale, the director directly owned 17,131 shares of the company’s stock, valued at $2,633,719.94. The trade was a 3.93% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, COO James Woys purchased 10,000 shares of the business’s stock in a transaction on Monday, August 4th. The shares were acquired at an average cost of $155.94 per share, for a total transaction of $1,559,400.00. Following the completion of the transaction, the chief operating officer directly owned 74,331 shares in the company, valued at approximately $11,591,176.14. This represents a 15.54% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 1.10% of the company’s stock.

Institutional Investors Weigh In On Molina Healthcare

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Aptus Capital Advisors LLC acquired a new position in shares of Molina Healthcare during the 4th quarter worth about $264,000. BNP Paribas Financial Markets increased its stake in shares of Molina Healthcare by 138.4% during the 4th quarter. BNP Paribas Financial Markets now owns 177,150 shares of the company’s stock worth $51,560,000 after purchasing an additional 102,840 shares during the last quarter. Centiva Capital LP acquired a new position in shares of Molina Healthcare during the 4th quarter worth about $1,235,000. Colonial Trust Co SC increased its stake in shares of Molina Healthcare by 930.0% during the 4th quarter. Colonial Trust Co SC now owns 103 shares of the company’s stock worth $30,000 after purchasing an additional 93 shares during the last quarter. Finally, Deutsche Bank AG increased its stake in shares of Molina Healthcare by 12.6% during the 4th quarter. Deutsche Bank AG now owns 338,460 shares of the company’s stock worth $98,509,000 after purchasing an additional 37,941 shares during the last quarter. 98.50% of the stock is owned by institutional investors.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.